Renewi Plc [RWI] vs Arcadis N.V [ARCAD] Detailed Stock Comparison
Renewi Plc
Euronext
Loading...
Arcadis N.V
Euronext
Loading...
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Renewi Plc wins in 6 metrics, Arcadis N.V wins in 13 metrics, with 0 ties. Arcadis N.V appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Renewi Plc | Arcadis N.V | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 27.11 | 15.70 | Arcadis N.V |
| Price-to-Book Ratio | 2.72 | 3.45 | Renewi Plc |
| Debt-to-Equity Ratio | 201.48 | 127.62 | Arcadis N.V |
| PEG Ratio | -0.18 | 11.34 | Renewi Plc |
| EV/EBITDA | 8.39 | 11.42 | Renewi Plc |
| Profit Margin (TTM) | -3.45% | 4.82% | Arcadis N.V |
| Operating Margin (TTM) | 5.00% | 7.05% | Arcadis N.V |
| EBITDA Margin (TTM) | 5.00% | 7.05% | Arcadis N.V |
| Return on Equity | 9.61% | 21.41% | Arcadis N.V |
| Return on Assets (TTM) | 2.73% | 6.30% | Arcadis N.V |
| Free Cash Flow (TTM) | $69.30M | $305.00M | Arcadis N.V |
| Dividend Yield | 0.58% | 2.29% | Arcadis N.V |
| 1-Year Return | 31.71% | -32.90% | Renewi Plc |
| Price-to-Sales Ratio (TTM) | 0.48 | 0.76 | Renewi Plc |
| Enterprise Value | $1.43B | $4.73B | Arcadis N.V |
| EV/Revenue Ratio | 0.83 | 0.96 | Renewi Plc |
| Revenue per Share (TTM) | $21 | $55 | Arcadis N.V |
| Earnings per Share (Diluted) | $0.38 | $2.65 | Arcadis N.V |
| Beta (Stock Volatility) | 1.01 | 0.88 | Arcadis N.V |
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends
Renewi Plc vs Arcadis N.V Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Renewi Plc | 0.00% | 0.39% | 1.58% | 1.38% | 5.53% | 6.30% |
| Arcadis N.V | 1.27% | -0.95% | 0.43% | -8.77% | -23.67% | -29.55% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Renewi Plc | 31.71% | 23.95% | 244.48% | 2,295.35% | 2,295.35% | 2,295.35% |
| Arcadis N.V | -32.90% | 21.14% | 121.51% | 89.18% | 176.41% | 536.09% |
Performance & Financial Health Analysis: Renewi Plc vs Arcadis N.V
| Metric | RWI | ARCAD |
|---|---|---|
| Market Information | ||
| Market Cap | €830.45M | €3.75B |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 17,123 | 173,756 |
| 90 Day Avg. Volume | 12,514 | 137,525 |
| Last Close | €10.30 | €41.60 |
| 52 Week Range | €6.70 - €10.33 | €38.88 - €66.85 |
| % from 52W High | -0.25% | -37.77% |
| All-Time High | €10.32 (Feb 24, 2025) | €66.85 (Nov 04, 2024) |
| % from All-Time High | -0.19% | -37.77% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.04% | -0.02% |
| Quarterly Earnings Growth | -0.75% | -0.05% |
| Financial Health | ||
| Profit Margin (TTM) | -0.03% | 0.05% |
| Operating Margin (TTM) | 0.05% | 0.07% |
| Return on Equity (TTM) | 0.10% | 0.21% |
| Debt to Equity (MRQ) | 201.48 | 127.62 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €3.78 | €12.07 |
| Cash per Share (MRQ) | €0.57 | €3.65 |
| Operating Cash Flow (TTM) | €186.50M | €289.00M |
| Levered Free Cash Flow (TTM) | €241.96M | €271.88M |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.58% | 2.29% |
| Last 12-Month Dividend | €0.06 | €1.00 |
Valuation & Enterprise Metrics Analysis: Renewi Plc vs Arcadis N.V
| Metric | RWI | ARCAD |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 27.11 | 15.70 |
| Forward P/E | 11.75 | 11.34 |
| PEG Ratio | -0.18 | 11.34 |
| Price to Sales (TTM) | 0.48 | 0.76 |
| Price to Book (MRQ) | 2.72 | 3.45 |
| Market Capitalization | ||
| Market Capitalization | €830.45M | €3.75B |
| Enterprise Value | €1.43B | €4.73B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.83 | 0.96 |
| Enterprise to EBITDA | 8.39 | 11.42 |
| Risk & Other Metrics | ||
| Beta | 1.01 | 0.88 |
| Book Value per Share (MRQ) | €3.78 | €12.07 |
Financial Statements Comparison: Renewi Plc vs Arcadis N.V
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | RWI | ARCAD |
|---|---|---|
| Revenue/Sales | N/A | N/A |
| Cost of Goods Sold | N/A | N/A |
| Gross Profit | N/A | N/A |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| EBITDA | N/A | N/A |
| Pre-Tax Income | N/A | N/A |
| Income Tax | N/A | N/A |
| Net Income (Profit) | N/A | N/A |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | RWI | ARCAD |
|---|---|---|
| Cash & Equivalents | €79.00M | €357.00M |
| Total Current Assets | €493.80M | €1.92B |
| Total Current Liabilities | €921.50M | €1.57B |
| Long-Term Debt | €574.40M | €964.00M |
| Total Shareholders Equity | €314.00M | €1.23B |
| Retained Earnings | €-259.20M | €929.00M |
| Property, Plant & Equipment | €0 | €0 |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | RWI | ARCAD |
|---|---|---|
| Operating Cash Flow | N/A | €98.70M |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | €96.65M |
| Debt Repayment | N/A | €-80.20M |
| Common Stock Repurchase | N/A | €-32,000 |
Short Interest & Institutional Ownership Analysis
| Metric | RWI | ARCAD |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Average Daily Volume (10 Day) | 17,123 | 173,756 |
| Average Daily Volume (90 Day) | 12,514 | 137,525 |
| Shares Outstanding | 80.55M | 89.41M |
| Float Shares | 63.04M | 72.93M |
| % Held by Insiders | 0.03% | 0.23% |
| % Held by Institutions | 1.00% | 0.52% |
Dividend Analysis & Yield Comparison: Renewi Plc vs Arcadis N.V
| Metric | RWI | ARCAD |
|---|---|---|
| Last 12-Month Dividend | €0.06 | €1.00 |
| Last 12-Month Dividend Yield | 0.58% | 2.29% |
| 3-Year Avg Annual Dividend | €0.02 | €0.86 |
| 3-Year Avg Dividend Yield | 0.76% | 1.82% |
| 3-Year Total Dividends | €0.06 | €2.59 |
| Ex-Dividend Date | Jun 27, 2024 | May 20, 2025 |